HUMA THERAPEUTICS LIMITED

Huma is a UK-based global digital health company providing AI-driven cloud platform solutions for healthcare organizations, pharmaceutical companies, and research institutions. The Huma Cloud Platform (HCP) is a regulated, enterprise-grade infrastructure that enables rapid development and deployment of clinical applications including remote patient monitoring, virtual care, clinical trial data capture, and population health management. The platform integrates analytics, machine learning, and AI agents to transform connected health data into actionable clinical intelligence. Huma's applications span primary care (myGP, eConsult), secondary care (Aluna respiratory, GDm gestational diabetes, eTriage emergency), clinical trials (Alcedis), and public health (population screening, CVD risk assessment). The platform holds regulatory clearances across multiple jurisdictions (FDA 510(k) Class II, MHRA Class IIb, EU MDR, TGA, CDSCO, Saudi FDA, MDSAP) and maintains ISO 13485, ISO 27001, and SOC 2 Type II compliance. Huma supports 100+ applications built by clients, serving 100+ global organizations and approximately 100 million patients. The company's integrated delivery model includes discovery, deployment, and federated scale-up phases for healthcare transformation at national scale.